(NHC) National HealthCare - Overview

Sector: HealthcareIndustry: Medical Care Facilities | Exchange NYSE MKT (USA) | Currency USD | Market Cap: 1.965m | Total Return 76.8% in 12m

Stock: Skilled Nursing, Senior Living, Home Health, Pharmacy

Total Rating 69
Risk 84
Buy Signal 0.23
Medical Care Facilities -7.2
Health Care Facilities -13.6
Market Cap: 1,965m
Avg Trading Vol: 15.6M USD
ATR: 3.58%
Peers RS (IBD): 84.2
Risk 5d forecast
Volatility 29.0%
Relative Tail Risk -5.02%
Reward TTM
Sharpe Ratio 1.99
Alpha 67.93
Character TTM
Beta 0.793
Beta Downside 1.295
Drawdowns 3y
Max DD 33.40%
CAGR/Max DD 1.33

EPS (Earnings per Share)

EPS (Earnings per Share) of NHC over the last years for every Quarter: "2021-03": 1.08, "2021-06": 6.8, "2021-09": -0.22, "2021-12": 1.02, "2022-03": 0.99, "2022-06": 0.21, "2022-09": -0.16, "2022-12": 0.4136, "2023-03": 0.79, "2023-06": 1.0626, "2023-09": 0.68, "2023-12": 1.8342, "2024-03": 1.6906, "2024-06": 1.7257, "2024-09": 2.7311, "2024-12": 0.3882, "2025-03": 2.0676, "2025-06": 1.52, "2025-09": 2.505, "2025-12": 1.5783,
EPS CAGR: 13.24%
EPS Trend: 66.9%
Qual. Beats: 0

Revenue

Revenue of NHC over the last years for every Quarter: 2021-03: 228.224, 2021-06: 248.032, 2021-09: 266.308, 2021-12: 268.378, 2022-03: 268.363, 2022-06: 271.039, 2022-09: 270.843, 2022-12: 264.036, 2023-03: 269.563, 2023-06: 282.582, 2023-09: 288.485, 2023-12: 300.914, 2024-03: 297.176, 2024-06: 291.213, 2024-09: 340.198, 2024-12: 369.35, 2025-03: 373.697, 2025-06: 374.91, 2025-09: 382.661, 2025-12: 384.789,
Rev. CAGR: 10.09%
Rev. Trend: 94.1%
Qual. Beats: 0

Description: NHC National HealthCare March 13, 2026

National HealthCare Corporation (NHC) operates a diverse portfolio of healthcare facilities and services. These include skilled nursing, assisted and independent living, homecare, hospice, and behavioral health services. The company also provides pharmacy and managed care insurance solutions, reflecting the integrated nature of modern healthcare provision.

NHCs skilled nursing facilities offer comprehensive rehabilitative and medical services, often catering to post-acute care needs. Assisted and independent living facilities provide varying levels of personal care and support for elderly residents, a growing demographic segment. Homecare and hospice agencies extend medical and supportive care into patients homes, aligning with preferences for in-home care.

The company also offers management, accounting, and financial services, and leases properties to third-party operators, indicating a diversified business model beyond direct patient care. Investors can find detailed financial data and further analysis on ValueRay.

Headlines to watch out for

  • Medicare and Medicaid reimbursement rates impact revenue
  • Labor costs and staffing shortages pressure margins
  • Regulatory changes in healthcare sector create uncertainty
  • Demand for senior care services drives occupancy
  • Investment in new facilities expands service offerings

Piotroski VR‑10 (Strict, 0-10) 9.5

Net Income: 120.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.10 > 0.02 and ΔFCF/TA 5.72 > 1.0
NWC/Revenue: 12.83% < 20% (prev 14.61%; Δ -1.78% < -1%)
CFO/TA 0.12 > 3% & CFO 185.1m > Net Income 120.0m
Net Debt (-23.9m) to EBITDA (222.8m): -0.11 < 3
Current Ratio: 1.77 > 1.5 & < 3
Outstanding Shares: last quarter (15.6m) vs 12m ago -0.12% < -2%
Gross Margin: 46.43% > 18% (prev 0.38%; Δ 4.61k% > 0.5%)
Asset Turnover: 99.39% > 50% (prev 85.14%; Δ 14.24% > 0%)
Interest Coverage Ratio: 11.49 > 6 (EBITDA TTM 222.8m / Interest Expense TTM 15.5m)

Altman Z'' 5.33

A: 0.13 (Total Current Assets 448.2m - Total Current Liabilities 253.6m) / Total Assets 1.53b
B: 0.55 (Retained Earnings 833.0m / Total Assets 1.53b)
C: 0.12 (EBIT TTM 177.9m / Avg Total Assets 1.53b)
D: 1.84 (Book Value of Equity 832.4m / Total Liabilities 451.9m)
Altman-Z'' Score: 5.33 = AAA

Beneish M -3.19

DSRI: 0.88 (Receivables 139.0m/135.8m, Revenue 1.52b/1.30b)
GMI: 0.81 (GM 46.43% / 37.52%)
AQI: 1.06 (AQ_t 0.23 / AQ_t-1 0.22)
SGI: 1.17 (Revenue 1.52b / 1.30b)
TATA: -0.04 (NI 120.0m - CFO 185.1m) / TA 1.53b)
Beneish M-Score: -3.19 (Cap -4..+1) = AA

What is the price of NHC shares?

As of March 29, 2026, the stock is trading at USD 161.03 with a total of 132,489 shares traded.
Over the past week, the price has changed by +1.40%, over one month by -1.51%, over three months by +16.58% and over the past year by +76.75%.

Is NHC a buy, sell or hold?

National HealthCare has no consensus analysts rating.

What are the forecasts/targets for the NHC price?

Issuer Target Up/Down from current
Wallstreet Target Price 6.2 -96.2%
Analysts Target Price 6.2 -96.2%

NHC Fundamental Data Overview March 28, 2026

P/E Trailing = 19.5401
P/E Forward = 9.8912
P/S = 1.6514
P/B = 2.3093
P/EG = 0.8241
Revenue TTM = 1.52b USD
EBIT TTM = 177.9m USD
EBITDA TTM = 222.8m USD
Long Term Debt = 32.5m USD (from longTermDebt, last quarter)
Short Term Debt = 41.1m USD (from shortTermDebt, last quarter)
Debt = 87.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -23.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.74b USD (1.96b + Debt 87.1m - CCE 309.2m)
Interest Coverage Ratio = 11.49 (Ebit TTM 177.9m / Interest Expense TTM 15.5m)
EV/FCF = 11.72x (Enterprise Value 1.74b / FCF TTM 148.6m)
FCF Yield = 8.53% (FCF TTM 148.6m / Enterprise Value 1.74b)
FCF Margin = 9.80% (FCF TTM 148.6m / Revenue TTM 1.52b)
Net Margin = 7.92% (Net Income TTM 120.0m / Revenue TTM 1.52b)
Gross Margin = 46.43% ((Revenue TTM 1.52b - Cost of Revenue TTM 812.2m) / Revenue TTM)
Gross Margin QoQ = 67.69% (prev 39.06%)
Tobins Q-Ratio = 1.14 (Enterprise Value 1.74b / Total Assets 1.53b)
Interest Expense / Debt = 11.41% (Interest Expense 9.93m / Debt 87.1m)
Taxrate = 21.59% (6.94m / 32.1m)
NOPAT = 139.5m (EBIT 177.9m * (1 - 21.59%))
Current Ratio = 1.77 (Total Current Assets 448.2m / Total Current Liabilities 253.6m)
Debt / Equity = 0.08 (Debt 87.1m / totalStockholderEquity, last quarter 1.07b)
Debt / EBITDA = -0.11 (Net Debt -23.9m / EBITDA 222.8m)
Debt / FCF = -0.16 (Net Debt -23.9m / FCF TTM 148.6m)
Total Stockholder Equity = 1.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.87% (Net Income 120.0m / Total Assets 1.53b)
RoE = 11.57% (Net Income TTM 120.0m / Total Stockholder Equity 1.04b)
RoCE = 16.63% (EBIT 177.9m / Capital Employed (Equity 1.04b + L.T.Debt 32.5m))
RoIC = 12.38% (NOPAT 139.5m / Invested Capital 1.13b)
WACC = 8.78% (E(1.96b)/V(2.05b) * Re(8.77%) + D(87.1m)/V(2.05b) * Rd(11.41%) * (1-Tc(0.22)))
Discount Rate = 8.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.51%
[DCF] Terminal Value 76.60% ; FCFF base≈113.7m ; Y1≈120.8m ; Y5≈144.7m
[DCF] Fair Price = 144.1 (EV 2.21b - Net Debt -23.9m = Equity 2.24b / Shares 15.5m; r=8.78% [WACC]; 5y FCF grow 6.95% → 3.0% )
EPS Correlation: 66.93 | EPS CAGR: 13.24% | SUE: N/A | # QB: 0
Revenue Correlation: 94.14 | Revenue CAGR: 10.09% | SUE: N/A | # QB: 0

Additional Sources for NHC Stock

Fund Manager Positions: Dataroma | Stockcircle